Blockchain Registration Transaction Record

GeoVax Backs WHO Call: Mpox Epidemic Persists, Urges Vaccine Supply Diversification

GeoVax endorses WHO warning on ongoing mpox epidemic, advancing GEO-MVA vaccine to diversify global supply. Learn about key milestones and impact on public health readiness.

This news matters because it highlights a critical gap in global health security: the ongoing mpox epidemic, particularly in Africa, fueled by vaccine shortages and inequitable access. With the world reliant on a single manufacturer for MVA vaccines, any disruption could leave populations vulnerable to outbreaks. GeoVax's GEO-MVA program aims to create a second supply source, enhancing resilience against future health crises. For readers, this underscores the importance of sustained investment in vaccine development and distribution to protect against infectious diseases that can rapidly cross borders, impacting public health, economies, and daily life worldwide.